UN

UnitedHealth Group Incorporated

UNHHealthcareNASDAQ

Healthcare Plans

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$447.57B
+11.8% YoY
Net Income
$12.06B
-16.3% YoY
EBITDA
$23.06B
-17.9% YoY
Free Cash Flow
$24.27B

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Positive CrossoverHistogram +0.7489, positive momentum
Sep 2 MACD Positive CrossoverHistogram +0.2583, positive momentum
About UnitedHealth Group Incorporated

Headquartered within the healthcare sector, UnitedHealth Group Incorporated focuses on Healthcare Plans services and products. UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. At a $359.79B market cap, UnitedHealth Group Incorporated ranks as a mega-cap company within healthcare. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.

Where UNH stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, UNH finished 12.31% above its 150-day moving average ($355.85) and 14.75% above its 200-day moving average ($348.30). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is UNH overbought or oversold?

At the September 3, 2026 close, UNH's RSI(14) was 50.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$359.79B
P/E (TTM)25.74
Fwd P/E17.87
EPS$15.57
Beta0.62
52W Change+14.5%
Dividend Yield2.34%
ROE14.1%
Analysis

The company holds $31.47B in cash, though total debt stands at $73.33B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $24.27B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 14.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $324.16B (2022) to $447.57B (2025), reflecting a 38% increase over the period.

UNH's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing UNH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms